Drug · DIN 02392569
TREANDA
FOR I.V. INFUSION. SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 9, 2018; first marketed September 12, 2012.
- Drug Identification Number (DIN)
- 02392569
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Bendamustine L01AA09
- Class
- Human
- Record last updated
- August 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BENDAMUSTINE HYDROCHLORIDE | 100 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 10, 2018: NOC 20296New Drug Submission (NDS) · Transfer of drug identification numbers
- August 24, 2012: NOC 13583New Drug Submission (NDS)
Other DINs named TREANDA
- DIN 02392550 · Marketed